OK-432 sclerotherapy in head and neck lymphangiomas: Long-term follow-up result

Nonsurgical treatments, such as sclerotherapy have been attempted for head and neck lymphagiomas. Of the available sclerosing agents, picibanil has shown satisfactory short-term treatment results in many studies, but no study has presented long-term treatment results. Accordingly, in the present stu...

Full description

Saved in:
Bibliographic Details
Published in:Otolaryngology-head and neck surgery 2009, Vol.140 (1), p.120-123
Main Authors: Yoo, Jae Chul, Ahn, Youngjin, Lim, Yune Syung, Hah, J. Hun, Kwon, Tack-Kyun, Sung, Myung-Whun, Kim, Kwang Hyun
Format: Article
Language:English
Subjects:
Adolescent
Adult
Child
Child, Preschool
Female
Follow-Up Studies
Head and Neck Neoplasms - therapy
Humans
Infant
Lymphangioma - therapy
Male
Picibanil - therapeutic use
Retrospective Studies
Sclerosing Solutions - therapeutic use
Sclerotherapy - methods
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Nonsurgical treatments, such as sclerotherapy have been attempted for head and neck lymphagiomas. Of the available sclerosing agents, picibanil has shown satisfactory short-term treatment results in many studies, but no study has presented long-term treatment results. Accordingly, in the present study, the authors retrospectively reviewed the long-term treatment results of picibanil sclerotherapy. Fifty-five lymphangioma patients who underwent picibanil sclerotherapy were enrolled. Data about initial and long-term response, recurrence, and excision rate were collected. Initial response rates were 83.5 percent and long-term response rates were 76.3 percent. Initial and the long-term response rate were equally good for lymphangioma.
ISSN:0194-5998
1097-6817
DOI:10.1016/j.otohns.2008.10.026